Pathogenesis of diabetic nephropathy

被引:162
作者
Raptis, AE
Viberti, G
机构
[1] Guys Kings & St Thomas Sch Med, Dept Diabet Endocrinol & Internal Med, Unit Metab Med, London SE1 9RT, England
[2] Univ Athens, Evangelismos Hosp, Inst Res, Dept Internal Med 2, GR-10679 Athens, Greece
[3] Univ Athens, Evangelismos Hosp, Ctr Diabet, GR-10679 Athens, Greece
关键词
diabetic nephropathy; AGEs; PKC; hemodynamic pathways; endothelial dysfunction;
D O I
10.1055/s-2001-18600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic Nephropathy (DN) is the commonest cause of end-stage renal failure (ESRF) in the Western world. Diabetic nephropathy follows a well outline clinical course, starting with microalbuminuria, there are various renal functional changes through proteinuria, azotaemia and culminating in ESRF Before the onset of overt proteinuria, there are various renal functional changes including renal hyperfiltration, hyperperfusion, and increasing capillary permeability to macromolecules. Basement-membrane thickening and mesangial expansion have long been recognized as pathological hallmark of diabetes. Tr has been postulated that DN occurs as a result of the interplay of metabolic and hemodynamic factors in the renal microcirculation. There is no doubt that there is a positive relationship between hyperglycaemia, which is necessary but not sufficient, and microvascular complications. The accumulation of advanced glycosylated end-products (AGEs), the activation of isoform(s) of protein kinase C (PKC) and the acceleration of the aldose reductase pathway may explain how hyper glycemia damages tissue. PKC is one of the key signaling molecules in the induction of the vascular pathology of diabetes. The balance between extracellular matrix production and degradation is important in this context. Transforming growth factor-beta a (TGF-beta) appears to play a pivotal role in accumulation in the diabetic kidney. Hemodynamic disturbances are believed to be directly responsible for the development of glomerulosclerosis and its attendant proteinuria. There is familial clustering of diabetic development of glomeruloscIerosis and its attendant kidney disease. A number of gene loci have been investigated to try to explain the genetic susceptibility to diabetic nephropathy. The genes coding for components of renin-angiotensin system have drawn special attention, due to the central role that this system plays in the regulation of blood pressure, sodium metabolism, and renal hemodynamics. Endothelial dysfunction is closely associated with the development of diabetic retinopathy, nephropathy and atherosclerosis, both in IDDM and in NIDDM. The pathogenesis of diabetic nephropathy is not clarified completely yet.
引用
收藏
页码:S424 / S437
页数:14
相关论文
共 50 条
  • [31] Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?
    Van Krieken, Richard
    Krepinsky, Joan C.
    CURRENT DIABETES REPORTS, 2017, 17 (03)
  • [32] 12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy
    Dong, Changqing
    Liu, Shengmao
    Cui, Yingchun
    Guo, Qiaoyan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 879
  • [33] Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathy
    Zerbini, Gianpaolo
    Gabellini, Daniela
    Maestroni, Silvia
    Maestroni, Anna
    JOURNAL OF NEPHROLOGY, 2007, 20 : S19 - S22
  • [34] Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C
    Ha, H
    Kim, KH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (2-3) : 147 - 151
  • [35] Molecular mechanisms of diabetic nephropathy and its therapeutic intervention
    Yamagishi, Sho-ichi
    Fukami, Kei
    Ueda, Seiji
    Okuda, Seiya
    CURRENT DRUG TARGETS, 2007, 8 (08) : 952 - 959
  • [36] Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice
    Li, Hong-Qin
    Liu, Nian
    Zheng, Zong-Yu
    Teng, Hao-Lin
    Pei, Jin
    WORLD JOURNAL OF DIABETES, 2022, 13 (08) : 600 - 612
  • [37] Therapeutic potential of SMAD7 targeting miRNA in the pathogenesis of diabetic nephropathy
    Rathan, V. Pooja
    Bhuvaneshwari, K.
    Adit, G. Nideesh
    Kavyashree, S.
    Thulasi, N.
    Geetha, A. V. S.
    Milan, K. L.
    Ramkumar, K. M.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2025, 764
  • [38] Upregulation of endothelin a receptor sites in the rabbit diabetic kidney: Potential relevance to the early pathogenesis of diabetic nephropathy
    Khan, MA
    Dashwood, MR
    Mumtaz, FH
    Thompson, CS
    Mikhailidis, DP
    Morgan, RJ
    NEPHRON, 1999, 83 (03): : 261 - 267
  • [39] The Glomerular Podocyte as a Target of Growth Hormone Action: Implications for the Pathogenesis of Diabetic Nephropathy
    Kumar, P. Anil
    Brosius, Frank C., III
    Menon, Ram K.
    CURRENT DIABETES REVIEWS, 2011, 7 (01) : 50 - 55
  • [40] Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
    Shivam, Asheesh Kumar
    Gupta, Asheesh Kumar
    Kumar, Sushil
    Kumar, Hitesh
    NATURAL PRODUCTS JOURNAL, 2024,